This year the European Association of Urology Conference was hosted in Madrid. With more that 10,000 attendees this is now the largest urology meeting in the world. This enabled Staffordshire Urology Consultant Lyndon Gommersall to further develop his skills in minimally invasive Da Vinci Robotic Prostatectomy and Minimally invasive laparoscopic cystectomy.
Staffordshire Urology Clinic surgeon Lyndon Gommersall explains the new Da Vinci Si Robotic surgical system.
If you are worried about prostate cancer or wish to discuss private assessment or treatment of prostate cancer please contact the North Staffordshire Nuffield Hospital on 01782 382507 and ask for an appointment with Mr Christopher Luscombe of Mr Lyndon Gommersall.
Staffordshire Urology clinic surgeons first in Staffordshire to perform robotic surgery for prostate cancer.
Christopher Luscombe and Lyndon Gommersall are extremely excited about this innovative development for the population of Staffordshire.
The new overactive bladder drug Mirabegron (Betmiga, Astellas) has recently been added to the joint Staffordshire drug formulary. This breakthrough drug in the treatment of overactive bladder and urgency urinary incontinence causes active relaxation of bladder muscle contraction and has been shown to reduce the number of times a patient voids during the day and decreases the number of incontinence episodes each day. This once a day treatment is the latest treatment for this debilitating condition with minimal side effects. At the Staffordshire Urology Clinic we continue to offer bladder botox injections, peripheral tibial nerve stimulation (PTNS) and in depth empathetic assessment, advice and treatment for all patients with bladder dysfunction.
Lyndon Gommersall Consultant Urological Surgeon at the Staffordshire Urology Clinic joined colleagues from Mediwatch to train JCB occupational health nurses to perform the finger prick PSAwatch point of care PSA blood test. This innovative project to test JCB employees over the age of 50 years at their place of work for prostate cancer has been developed in line with the national prostate cancer risk management programme. Promoting Men’s Health in the workplace is an important method of improving men’s early attendance to their doctor with symptoms that can lead to a diagnosis of cancer. By offering an information leaflet and the PSA point of care blood test men will get instant reassurance if their PSAwatch blood test is normal and have an ‘at work’ review by a Consultant Urological Specialist if a test is abnormal or other concerns are raised. For more information about PSA blood testing in the workplace please contact us
British Association of Urological Surgeons – Manchester 2013
Each of our urology surgical consutlants attended this important national conference in Manchester last week. Encompassing all aspects of contemporary urological care it ensures that our specialists are up to date with the latest in the investigation treatment and management of our patients.
Gender inequalities in the promptness of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open June 2013
Women with bladder and renal cancer are more likely than men to require three or more consultations with their general practitioner before they are referred to a hospital specialist. They also experience longer time intervals between presentation and hospital referral. These include gender differences for patients both with and without blood in the urine (haematuria), suggesting that doctors often interpret the clinical importance of haematuria differently in men and women. This is thought to be due to the higher risk of urinary infections in women than men. Blood in the urine is a key symptom in the diagnosis of these serious but treatable diseases. If you experience blood in the urine you should see your doctor immediately and they will decide if you need referring on to a specialist. At the Staffordshire Urology Clinic we offer state of the art investigation of blood in the urine and highly specialist management of both kidney and bladder cancer including key hole (laparoscopic surgery).
The Staffordshire Urology Clinic Frequency / Volume Chart can now be downloaded.
This chart is designed to measure how much you drink. It also allows your doctor to calculate how much urine you pass and how often. It helps to diagnose why you have urinary symptoms. The chart should be completed over 5 consecutive days if possible.
This is an essential element in the assessment of both male and female patients with urinary symptoms.
Click to download the Staffordshire Urology Clinic Frequency / Volume Chart here.
Vasectomy can be reversed to restore fertility. It is not always successful and the longer it has been since vasectomy the less successful it becomes. Our Consultants often use magnification to improve the surgery and have approximately a 90% success rates (first time reversal) at restoring sperm to the semen.
We reviewed the last 33 first time vasectomy reversal procedures performed by Mr Luscombe up until the end on 2017. We identified 25 patients who had provided post vasectomy reversal semen samples; of these 22 were positive for sperm. Of the 8 that did not provide semen samples some had already communicated a successful pregnancy. Thus, the patency rate is between 88% and 91%. This compares favourable to an average patency rate of 89.4% reported in a review of 6633 patients from the world literature. This review was reported by Herrel et al and published in the Journal Urology (2015 ).
After an initial consultation the Staffordshire Urology Clinic can arrange a vasectomy reversal for £3053 (correct 23/01/2013, but may change so please confirm directly with the Hospital). If you would like to discuss Vasectomy with one of our consultants please contact 01782 382507 and book an appointment.